SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced fiscal year 2025 financial results. FY2025 Financial Highlights (all metrics compared to FY2024 unless otherwise noted)Revenue was $6,841,250, an increase of 5% compared to $6,532,000. Consolidated clinic revenue increased 4% to $6,721,057, compared to $6,450,431. Revenue from all clinics was $8,021,929, including both consolidated and equity method clinics, an increase of 4% compared to $7,731,177. Net loss from continuing operations was $(5.3) million compared to $(7.7) million. Adjusted EBITDA (see table included) was $(3.2) million compared...

SPRINGFIELD, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Village Super Market, Inc. (NSD-VLGEA) today reported its results of operations for the third quarter ended April 25, 2026. Third Quarter of Fiscal 2026 HighlightsNet income of $9.0 million, or $0.61 per Class A diluted share Sales increased 1.6% and same store sales decreased 0.2% Excluding the estimated impact of Winter Storm Fern on the first week of the quarter, same store sales increased 1.3% Same store digital sales increased 9%Year-To-Date Fiscal 2026 HighlightsNet income of $38.8 million, or $2.62 per Class A diluted share Sales increased 4.4% and same store sales increased 2.4% Same store digital sales increased 13%Third Quarter of Fiscal 2026 Results Sales were $572.6 million in the 13 weeks ended April 25, 2026 compared to $563.7 million in the 13 weeks ended...

Net Sales Increased 15% to $1.560 Billion, Exceeding Guidance Operating Income Increased to $76 Million; Adjusted Operating Income of $80 Million Exceeds Guidance VS&Co Raises Full Year 2026 Net Sales Guidance to $7.030-$7.130 Billion and Adjusted Operating Income Guidance to $550-$580 MillionREYNOLDSBURG, Ohio, June 02, 2026 (GLOBE NEWSWIRE) — Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSXY) today reported financial results for the first quarter ended May 2, 2026. Hillary Super, VS&Co Chief Executive Officer, said, “We delivered a very strong start to 2026, exceeding top- and bottom-line guidance and continuing the momentum we built in the back half of last year. We drove double-digit sales growth across Victoria’s Secret, PINK, and Beauty, as well as our fourth consecutive quarter of positive...

First quarter net revenue of $197.9 million, down approximately 26% year-over-year First quarter adjusted EBITDA of $(7.0) million First quarter net loss of $(21.4) million and first quarter adjusted net loss of $(9.8) million Strong liquidity position including cash, cash equivalents and investments of $667.4 million, and aggregate credit facilities of $350 million which remain undrawnNEW YORK, June 02, 2026 (GLOBE NEWSWIRE) — ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the first quarter ended March 31, 2026. “We continue to implement our recovery plan to address the account dislocation with our largest advertising partner and we remain hopeful that we are on track for normalization in the second half of this year,” said Oran Holtzman, ODDITY co-founder and CEO. “For many years, our CPA was very...

Achieved record first quarter results, underscoring the continued strength of Yesway’s operating platform and consistent execution Delivered same-store inside sales growth in 12 of the past 13 quarters and generated positive fuel gallons growth in the first quarter of fiscal 2026 Introduced fiscal year 2026 outlook, reflecting confidence in Yesway’s growth strategy, operating momentum, and ability to create long-term shareholder value FORT WORTH, Texas, June 02, 2026 (GLOBE NEWSWIRE) — Yesway, Inc. (“Yesway” or the “Company”) (Nasdaq: YSWY), one of the fastest-growing convenience store operators in the U.S., today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsNet income increased to $30.2 million from a net loss of $5.6 million in the prior-year period, and Adjusted EBITDA...

SINGAPORE, June 02, 2026 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (NASDAQ: TIGR) (“UP Fintech” or the “Company”), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the first quarter ended March 31, 2026. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated: “In the first quarter, we continued to expand our user base and client assets, while further optimizing our comprehensive product offerings. Supported by these solid fundamentals, both our topline and operating performance have achieved notable year-over-year growth. Our total revenue for the first quarter reached US$154.9 million, representing a 26.3% increase year over year. Net loss and non-GAAP net loss attributable to UP Fintech for the quarter were $26.9 million and $23.8 million, versus net income of...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. CASCAIS, Portugal, June 02, 2026 (GLOBE NEWSWIRE) — Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company“), a primary helium company, is pleased to announce its financial and operating results for the six months ended March 31, 2026 (the “Period”). Selected financial and operational information is outlined below...

Gross Revenue of US$47.04 Million and Cash Cost of US$1,390/Oz VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its financial results for the three months (“Q3 FY 2026”) and nine months ended March 31, 2026 (“YTD FY 2026”). All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). President and CEO Cathy Zhai commented, “We are very pleased that the Company has reached a net profit of $22.65 million during Q3, or net earnings of $0.07 per share, which bringing year to date net profit to $53.31 million, or net earnings of $0.15/share. The Selinsing Gold Mine in Malaysia continues delivering favorable production results, together with high gold price, the Company’s...

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three months ended March 31, 2026 (“Q1 2026”), and provided an update on recent corporate developments. Q1 2026 Financial HighlightsResearch and development (R&D) expenses of $1,031,556, up from $885,594 in Q1 2025, reflecting expanded chemistry, AI research, and contract research activity supporting the advancement of the Company’s AI-powered oncology pipeline. General and administrative (G&A) expenses of $443,986, down from $1,224,752 in Q1 2025 — a reduction of approximately 64% — reflecting...

First quarter 2026 revenue up 79.4% compared to the first quarter of 2025 First quarter 2026 gross profit increased 71.9% compared to the first quarter of 2025 First quarter same-store sales were up 7.3%, and same-store prescription sales were up 7.2%, both compared to the first quarter of 2025SASKATOON, Saskatchewan, June 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the first quarter ended March 31, 2026. “We further scaled our business in the first quarter by successfully integrating our recent pharmacy acquisitions, and advancing our unique and expanding pipeline of additional M&A opportunities,” said Alan Simpson, Executive Chairman of PharmaCorp. “We believe our growth...